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Abstract
Background: Our previous study showed that, in basal cell carcinoma cells, arecoline reduces levels of the tumor cell 
survival factor interleukin-6 (IL-6), increases levels of tumor suppressor factor p53, and elicits cell cycle arrest, followed 
by apoptosis. In preliminarily studies, we observed that arecoline induces detachment of the human-derived 
hepatoma cell line HA22T/VGH from the extracellular matrix. In the present study, we explored the fate of the detached 
HA22T/VGH cells and investigated the underlying mechanism.
Methods: HA22T/VGH cells or primary cultured rat hepatocytes were treated with arecoline, then changes in 
morphology, viability, apoptosis, and the expression of surface β1-integrin, apoptosis-related proteins, and IL-6 were 
examined. Furthermore, activation of the signal transducer and activator of transcription 3 (STAT3) pathway and the 
RhoA/Rock signaling pathway, including p190RhoGAP and Src homology-2 domain-containing phosphatase SHP2, 
was examined.
Results: A low concentration of arecoline (≤ 100 μg/ml) caused cytoskeletal changes in HA22T/VGH cells, but not 
hepatocytes, and this was accompanied by decreased β1-integrin expression and followed by apoptosis, indicating 
that HA22T/VGH cells undergo anoikis after arecoline treatment. IL-6 expression and phosphorylation of STAT3, which 
provides protection against anoikis, were inhibited and levels of downstream signaling proteins, including Bcl-XL and 
Bcl-2, were decreased, while Bax expression, mitochondrial cytochrome c release, and caspase-3 activity were 
increased. In addition, phosphorylation/activation of p190RhoGAP, a RhoA inhibitor, and of its upstream regulator, 
SHP2, was inhibited by arecoline treatment, while Rho/Rock activation was increased. Addition of the RhoA inhibitor 
attenuated the effects of arecoline.
Conclusions: This study demonstrated that arecoline induces anoikis of HA22T/VGH cells involving inhibition of STAT3 
and increased RhoA/Rock activation and that the STAT3 and RhoA/Rock signaling pathways are connected.
Background
Arecoline has been suggested as a possible cognition
enhancer in Alzheimer's type dementia [1,2]. Recent
studies have shown that it decreases interleukin-6 (IL-6)
production in keratinocytes and KB cancer cells [3,4]. In
addition, Chang et al. [3] reported that arecoline elicits
cell cycle deregulation in KB cancer cells. Moreover, our
previous study [Chang et al.: Arecoline decreases inter-
leukin-6 production and induces apoptosis and cell cycle
arrest in human basal cell carcinoma cells (BCC/KMC),
submitted] showed that, in basal cell carcinoma cells, are-
coline reduces levels of the tumor cell survival factor IL-6,
increases levels of the tumor suppressor factor p53, and
elicits cell cycle arrest, followed by apoptosis, showing
that arecoline interferes with cancer cell cycle progres-
sion. Our preliminary data showed that arecoline induces
detachment of the hepatoma cell line HA22T/VGH from
the extracellular matrix (ECM).
Adherence of epithelial cells to the ECM is important
for cell growth and survival and detachment from the
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ECM induces cell apoptosis, known as anoikis [5,6]. The
expression of certain oncogenes, such as activation of sig-
nal transducer and activator of transcription 3 (STAT3)
[7], phosphatidylinositol 3-kinase (PI3K)/Akt [8], and Src
[8], provides anchorage-independent growth ability and
protection against anoikis, and this protection is thought
to be critical during tumorigenesis.
The small GTPase RhoA has emerged as a pivotal con-
trol point through which cells sense changes in ECM
mechanics and cytoskeletal organization and translate
the 'cell shape signal' to downstream effectors that medi-
ate these behaviors [8]. RhoA activity can be suppressed
by any one of a variety of different RhoGAP proteins.
p190RhoGAP has been shown to be phosphorylated by
Src tyrosine kinase when cells first attach to the ECM
substrate and integrin receptors become ligated, allowing
p190RhoGAP to exert its RhoGAP activity and leading to
inactivation of RhoA [9,10]. Cell detachment and round-
i n g  i n  m i t o s i s  h a v e  a l s o  b e e n  r e p o r t e d  t o  i n h i b i t
p190RhoGAP activity and increase RhoA activity [11].
Src homology-2 domain-containing phosphatases
(SHPs) are a small, highly conserved subfamily of protein-
tyrosine phosphatases, members of which are present in
both vertebrates and invertebrates. In most receptor
tyrosine kinase signaling pathways, SHP2 is required for
full activation [12]. SHP2 has been reported to play an
essential role in integrin signaling, and dominant-nega-
tive mutants of SHP2 inhibit integrin-stimulated focal
adhesion and stress fiber turnover, cell spreading, and
proliferation [12].
In the present study, we explored the fate of the
HA22T/VGH cells detached by the action of arecoline
and investigated the underlying mechanisms of this
detachment. Cytokine IL-6 expression and activation of
its downstream effector STAT3 and expression and acti-
vation of RhoA/Rock, p190RhoGAP, and SHP2 were also
examined. Our results showed that arecoline induces
anoikis in HA22T/VGH cells by inhibiting the activation
of STAT3, SHP2 and p190RhoGAP and enhancing the
activation of RhoA/Rock.
Results
Arecoline induces cell detachment, followed by apoptosis
As in our preliminary study, some HA22T/VGH cells
became detached after 24 h of treatment with 30 or 100
μg/ml of arecoline, and more became detached after 48 h
of treatment (Fig. 1A). This arecoline-induced cell
detachment was accompanied by decreased expression of
the cell surface adhesion molecule β1-integrin (Fig. 1B).
To clarify whether this detachment was due to cell cycle
progression, we examined the distribution of cell cycle
phases and found there was no difference with or without
arecoline treatment (data not shown). Having excluded
cell cycle progression, we explored the fate of these
detached cells and examined the effects of arecoline on
normal rat hepatocytes. Interestingly, no detachment of
normal hepatocytes was seen with arecoline treatment.
After 72 h of arecoline treatment, the viability of normal
hepatocytes was not significantly changed, whereas that
of HA22T/VGH cells decreased in a dose-dependent
manner (Fig. 1C). In addition, DNA fragmentation was
seen in arecoline-treated HA22T/VGH cells and was
restricted to the detached cells (Fig. 1D). As shown in Fig.
1E, more than 90% of the detached cells were positive for
Figure 1 Arecoline induces detachment of HA22T/VGH cells, fol-
lowed by apoptosis. (A) HA22T/VGH cells were treated with 0 (left), 30 
(center), or 100 (right) μg/ml of arecoline for 24 h or 48 h, then cell mor-
phology was observed under a phase-contrast microscopy at 200× 
magnification. The black arrows indicate detached cells. (B) After treat-
ment of arecoline for 24 h, β1-integrin expression was measured by 
flow cytometric analysis using RPE-conjugated antibody. The histo-
gram of red filled area is the untreated control and the black lines the 
treated groups. The values shown are the mean fluorescence intensity 
as a percentage of the untreated control value. (C) HA22T/VGH cells or 
primary normal rat hepatocytes were treated with the indicated con-
centration of arecoline for 72 h, then viable cells were counted using 
Trypan blue and the results expressed as a percentage of the untreated 
control value. (D) After treatment of arecoline for 72 h, the cells were 
harvested all together or the detached and adherent cells separately 
and genomic DNA extracted and analyzed on an agarose gel for DNA 
fragmentation. The left panel shows the total cells and the right panel 
adherent and detached cells separately. (E) TUNEL staining of the de-
tached cells detected by flow cytometric analysis. The green filled area 
is the untreated control and the black lines the treated groups. The val-
ues shown are the percentage of TUNEL-positive cells in the detached 
cells. All data are the mean ± S.D. for three independent experiments. 
*: p < 0.05 as compared to the untreated control.Cheng et al. Molecular Cancer 2010, 9:126
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TUNEL staining over the concentration range of 10 μg/
ml to 60 μg/ml arecoline, while only 74% were positive at
the concentration of 100 μg/ml, which could be explained
by the fact that some of the detached cells had died.
These results demonstrate that arecoline induces
HA22T/VGH detachment, followed by apoptosis.
Expression of apoptosis-related proteins and caspase 
activity
To determine whether this arecoline-induced apoptosis
was associated with altered expression of apoptosis-regu-
lated proteins, HA22T/VGH cells were treated for 24 h
with 30 or 100 μg/ml of arecoline. At 100 μg/ml of areco-
line, Western blots showed a significant decrease in Bcl-
2, Bcl-XL, and procaspase-9 levels and a significant
increase in Bax levels and cytochrome c release (Fig. 2A).
Members of the caspase family are expressed in cells as
inactive procaspases, which are activated during apopto-
sis. As shown in Fig. 2B, treatment of HA22T/VGH cells
for 24 h with 100 μg/ml of arecoline resulted in a marked
increase in active caspase-3, as shown by flow cytometry
using an antibody against active caspase-3. These results
show that arecoline induces apoptosis by caspase-3 acti-
vation and a reduction in expression of anti-apoptotic
proteins.
Arecoline decreases IL-6 expression and STAT3 activation
Several studies have reported that anti-apoptotic genes
are regulated by IL-6 and STAT3 [13,14]. Moreover, in
the liver, STAT3 is mainly activated by IL-6 and related
cytokines and promotes anchorage-independent growth
[15-17]. To examine whether arecoline had an effect on
IL-6 and/or STAT3 levels, HA22T/VGH cells were
treated with 1-100 μg/ml of arecoline for 24 h, then IL-6
m R N A  l e v e l s  w e r e  m e a s u r e d  b y  q u a n t i t a t i v e  r e a l - t i m e
PCR and levels of gp130 (an IL-6 signal transducing
receptor component) and Tyr705 phosphorylated STAT3
(the active form of STAT3) were assayed by Western blot-
ting. Table 1 shows that arecoline at concentrations of 30-
100 μg/ml markedly decreased IL-6 expression, while Fig.
3 shows that levels of gp130 or activated gp130 were not
altered by arecoline, while Tyr705 phosphorylation of
STAT3 was markedly inhibited.
Arecoline inhibits p190RhoGAP and SHP2 activation and 
increases Rho-associated kinase
p190RhoGAP is phosphorylated by Src tyrosine kinase,
allowing it to exert its RhoGAP activity, leading to inacti-
vation of RhoA [9,10]. Fig. 3 shows that, after 24 h of are-
coline treatment, p190RhoGAP levels were significantly
decreased at the concentration of 100 μg/ml of arecoline,
while levels of the active phosphorylated p190RhoGAP
were decreased at arecoline concentrations higher than 3
μg/ml. Src homology-2 domain-containing phosphatases
(SHPs) are present in vertebrates and invertebrates. SHP2
plays an essential role in integrin signaling [12] upstream
of RhoA to regulate its activity [18]. As shown in Fig. 3,
after 24 h of arecoline treatment, the amount of SHP2
was not changed, but the amount of active phosphory-
lated SHP2 was decreased at arecoline concentrations
higher than 30 μg/ml. Furthermore, Rho-associated
kinase-1 (Rock-1) was cleaved to generate an active
cleaved form at arecoline concentrations higher than 3
μg/ml. The decreased activation of p190RhoGAP and
SHP2 might result in enhanced RhoA activity and activity
of its effector, Rock.
Arecoline stimulates actin stress fiber formation
RhoA induces assembly of actin-myosin filaments
through activation of Rock kinase [19]. Since arecoline
was found to increase the amount of active Rock, we
examined whether it also stimulated actin stress fiber for-
mation. After treatment with arecoline for 24 h, actin
stress fiber formation was increased (Fig. 4A) and was
increased by almost 6-fold at the concentration of 100 μg/
ml arecoline compared to the control (Fig 4B).
Figure 2 Arecoline alters the expression of apoptosis-related 
proteins and caspase activity in HA22T/VGH cells. (A) HA22T/VGH 
cells were treated with 0, 30, or 100 μg/ml of arecoline for 24 h, then 
the cells were harvested and proteins extracted and used for Western 
blotting for Bcl-2, Bcl-XL, Bax, cytochrome c, or procaspase-9. β-actin 
was used as the internal control. The values shown are the quantitative 
density analysis expressed as the relative density compared to that in 
untreated cells (control), taken as 100%. The results are expressed as 
the mean ± S.D. for three separate experiments. (B) Caspase-3 activity 
was detected using RPE-conjugated anti-active caspase-3 antibody by 
flow cytometric analysis. The values shown are the percentage of cells 
with active caspase-3 and are the mean ± S.D. of three independent 
experiments. The red filled area is the untreated control and the black 
lines the treated groups. *: p < 0.05 as compared to the untreated con-
trol.Cheng et al. Molecular Cancer 2010, 9:126
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A RhoA inhibitor attenuates the effects of arecoline
In order to verify the hypothesis that arecoline exerted its
effects through the RhoA pathway, we treated HA22T/
VGH cells with the RhoA inhibitor C3 exoenzyme for 1 h
before, and during arecoline treatment and found that
arecoline-induced actin stress fiber formation was
reduced (Fig. 5A and 5B) and cell detachment decreased
(data not shown). Western blotting (Fig. 6) showed RhoA
was inhibited by ADP-ribosylation when C3 exoenzyme
was added, as shown by the shift of the RhoA band to a
higher molecular weight, whereas the amounts of the
active phosphorylated forms of STAT3, p190RhoGAP,
and SHP2 were increased. These results demonstrated
that all of the effects of arecoline on HA22T/VGH cells
were attenuated by addition of the RhoA inhibitor, show-
ing that these effects occurred mainly through the RhoA
pathway.
IL-6 addition has no effect on the arecoline-induced 
reduction in STAT3 activation
To examine whether the arecoline-induced reduction in
STAT3 activation could be reversed by addition of IL-6,
HA22T/VGH cells were pretreated for 1 h with recombi-
nant IL-6 (100 ng/ml), then co-treated with arecoline for
24 h and proteins were examined by Western blotting.
Unexpectedly, as shown in Fig. 7, STAT3 activation was
not reversed after IL-6 addition, nor were levels of its
d o w n s t r e a m  e f f e c t o r  B c l - 2 ,  t o t a l  o r  a c t i v a t e d
p190RhoGAP, or activated Rock, whereas activated phos-
p h o r y l a t e d  S H P 2  l e v e l s  w e r e  i n c r e a s e d .  T h e s e  r e s u l t s
show that the reduction in STAT3 activation caused by
arecoline was not due solely to decreased IL-6 expression
and that other pathway(s) might be involved.
Arecoline interferes with the anchorage-independent 
growth of HA22T/VGH cells
To examine the effect of arecoline on anchorage-inde-
pendent growth in vitro, we measured the colony forma-
tion ability of hepatoma cells in soft agar. Consistent with
the above data, the ability of HA22T/VGH to grow in soft
agar was markedly inhibited by arecoline (Fig. 8).
Discussion
In this study, we found that arecoline induced HA22T/
VGH hepatoma cells to undergo anoikis. In terms of
reducing cell viability, arecoline was effective on HA22T/
Table 1: Relative quantitation of IL-6 expression in HA22T/VGH after arecoline treatment by quantitative real-time PCR method.
Arecoline (μg/ml) IL-6 GAPDH ΔCta ΔΔCtb related to controlc
0 28.70 ± 0.09 17.34 ± 0.07 11.36 ± 0.11 0 ± 0.11 1.00
(0.92-1.08)
3 28.67 ± 0.11 17.28 ± 0.06 11.39 ± 0.13 0.03 ± 0.13 0.98
(0.90-1.07)
30 29.11 ± 0.06 17.23 ± 0.08 11.88 ± 0.10 0.52 ± 0.10 0.70*
(0.65-0.75)
100 31.54 ± 0.08 17.67 ± 0.03 13.87 ± 0.09 2.51 ± 0.09 0.18#
(0.17-0.19)
a: The ΔCt value is determined by subtracting the average GAPDH Ct value from the average IL-6 Ct value. All data are the mean ± standard 
deviation. b: The ΔΔCt value is determined by subtracting the control ΔCt value from the treatment ΔCt value. c: The range given for IL-6 relative 
to control is determined by evaluating the expression: 2(-ΔΔCt) with ΔΔCt+S.D. and ΔΔCt-S.D., where S.D. = the standard deviation of the ΔΔCt 
value. *: p < 0.05; #: p < 0.001 as compared to the untreated control.
Figure 3 Arecoline inhibits activation of STAT3, p190RhoGAP, 
and SHP2 and increases Rock-1 cleavage in HA22T/VGH cells. 
HA22T/VGH cells were treated with 0-100 μg/ml of arecoline for 24 h, 
then the cells were harvested and proteins extracted and used for 
Western blotting with antibodies against Gp130, phospho-Tyr705-
STAT3 (STAT3-Tyr-p), p190RhoGAP, SHP2, or Rock-1; the Gp130, 
p190RhoGAP, and SHP2 blots were then stripped and re-blotted using 
antibodies against phospho-Tyr (Tyr-p). β-actin was used as the inter-
nal control. The values shown are the quantitative density analysis ex-
pressed as the relative density compared to that in untreated cells 
(control), taken as 100%. The results are expressed as the mean ± S.D. 
for three separate experiments. *: p < 0.05 as compared to the untreat-
ed control.Cheng et al. Molecular Cancer 2010, 9:126
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VGH cells, but not on normal hepatocytes. In HA22T/
VGH cells, arecoline caused actin stress fiber formation,
resulting in cytoskeletal changes and subsequent apopto-
sis. Furthermore, IL-6 expression and phosphorylation of
its downstream effectors, STAT3, Bcl-2, and Bcl-XL, all of
which provide protection against anoikis, were
decreased. However, the arecoline-induced reduction in
STAT3 activation could not be reversed by addition of IL-
6. In addition, phosphorylation of p190RhoGAP, a RhoA
inhibitor, and of its upstream regulator, SHP2, was
decreased and Rock-1, the downstream effector of RhoA,
was activated (Fig. 9). These effects were attenuated when
a RhoA inhibitor was added, showing that the RhoA
pathway was involved in the effects of arecoline on
HA22T/VGH cells.
I n  t h e  l i v e r ,  S T A T 3  i s  m a i n l y  a c t i v a t e d  b y  I L - 6  a n d
related cytokines [15,16]. In the IL-6 signaling pathway,
the functional IL-6 receptor complex is composed of an
IL-6 receptor that binds IL-6 and a signal transducing
receptor component, gp130 [20]. After binding to gp130,
STAT3 becomes tyrosine-phosphorylated by JAK
kinases, dissociates from the receptor, dimerizes, and
translocates to the nucleus [20]. STAT3 has been shown
to be constitutively active in a growing number of diverse
human cancer cell lines and tumor tissues [13,14], includ-
ing hepatoma cells [21]. Many proteins that are crucial for
tumor cell proliferation and survival have been found to
be regulated by STAT3; these include Bcl-2, Bcl-XL, cyclin
D1/D2 [13,14] and IL-6 [22], which are considered to
contribute to the anoikis resistance-inducing property of
STAT3. We found that arecoline treatment resulted in a
marked reduction in phospho-Tyr705 STAT3 and down-
regulation of its downstream signaling proteins, IL-6,
Bcl-XL, and Bcl-2. Interestingly, the reduction in STAT3
activation caused by arecoline was not reversed by addi-
tion of IL-6. Thus, we propose that the STAT3 inactiva-
Figure 4 Arecoline increases actin stress fiber formation in 
HA22T/VGH cells. HA22T/VGH cells were treated with 0, 10, 30, 60, or 
100 μg/ml of arecoline for 24 h, then were fixed with paraformalde-
hyde for actin labeling and observation by fluorescence microscopy 
(A) or flow cytometry (B). In A, panel AC is untreated cells incubated 
with second antibody alone, and C is the untreated control group in-
cubated with primary and secondary antibodies. The values shown in 
B are the percentage of actin staining-cells and are the mean ± S.D. for 
three independent experiments. The green filled area is the untreated 
control and those delimited by the black lines the treated groups. *: p 
< 0.05 as compared to the untreated control.
Figure 5 The RhoA inhibitor, C3 exoenzyme, abolishes arecoline-
induced actin stress fiber formation. (A) HA22T/VGH cells were left 
untreated (C), treated with 1.5 μg/ml of C3 exoenzyme for 25 h (Ri1.5), 
with 100 μg/ml of arecoline for 24 h (A100), or with C3 exoenzyme for 
1 h, then with 100 μg/ml of arecoline in the continued presence of C3 
exoenzyme for 24 h (Ri1.5+A100), then were fixed with paraformalde-
hyde for actin labeling and observation of stress fiber by fluorescence 
microscopy (A) or flow cytometry (B). In B, the values are the percent-
age of actin staining-cells and are the mean ± S.D. for three indepen-
dent experiments. The green filled area is the untreated control and 
those delimited by the black lines the treated groups. *: p < 0.05 as 
compared to the untreated control; #: p < 0.05 as compared to the are-
coline (A100) treatment.Cheng et al. Molecular Cancer 2010, 9:126
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tion caused by arecoline does not occur solely through
the IL-6 signaling pathway and that other pathway(s) are
involved.
Because of its cholinergic properties, arecoline has
been used to improve verbal memory in patients with
Alzheimer's disease [1,2]. Arecoline exerts its effects
mainly via M1, M2, and M3 muscarinic acetylcholine
receptors [23-25]. Previous studies have shown that rat
hepatocytes express M3 receptors [26]. Further, muscar-
inic receptor-elicited signals have been shown to affect
liver metabolism [26]. Muscarinic receptors are coupled
to G proteins. Activation of the G protein-coupled M3
receptor regulates cell growth [27,28], and the involve-
ment of RhoA as a downstream effector in M3 receptor-
coupled signals has been established [29]. We therefore
suppose that arecoline acts on RhoA activity through M3
receptor-coupled G proteins. In addition, our results
showed that the activation/phosphorylation of
p190RhoGAP, a RhoA inhibitor, was inhibited by areco-
line, which would also enhance RhoA activity.
Apoptosis is characterized by marked morphological
changes, including contraction and membrane blebbing.
RhoA and its effector Rho-associated kinase (Rock) are
involved in the actin-myosin system and have been impli-
cated as the source of the contractile force that drives
these morphological changes [19]. A recent study demon-
strated that RhoA is involved in tension-dependent death
upon cell detachment [8]. RhoA activation increases the
cell tension by promoting stress fiber formation, forcing
cell detachment and apoptosis. Moreover, a recent report
showed that RhoA and Rock also upregulate Bax to acti-
Figure 6 The RhoA inhibitor attenuates the effects of arecoline 
on STAT3, p190RhoGAP, and SHP2 in HA22T/VGH cells. Cells were 
left untreated or were treated with arecoline alone or arecoline plus C3 
exoenzyme as in Fig. 5, then were harvested and proteins were extract-
ed preparing for Western blotting for RhoA, phospho-Tyr705-STAT3 
(STAT3-Tyr-p), phospho-Tyr (Tyr-p) p190RhoGAP, and phospho-Tyr 
(Tyr-p) SHP2, as described in the legend to Fig. 3. β-actin was used as 
the internal control. The values shown are the quantitative density 
analysis expressed as the relative density compared to that in untreat-
ed cells (control), taken as 100%. The results are expressed as the mean 
± S.D. for three separate experiments. *: p < 0.05 as compared to the 
untreated control; #: p < 0.05 as compared to the arecoline (A100) 
treatment.
Figure 7 Addition of IL-6 does not alter the effects of arecoline. 
HA22T/VGH cells were left untreated (C) or were incubated with 100 
μg/ml of arecoline for 24 h (A100), with 100 ng/ml of IL-6 for 25 h (IL-
6), or with IL-6 for 1 h, then with arecoline in the continued presence 
of IL-6 for 24 h (IL-6+A100). The cells were then harvested and proteins 
extracted and used for Western blotting for phospho-Tyr705-STAT3 
(STAT3-Tyr-p), Bcl-2, phospho-Tyr (Tyr-p) p190RhoGAP, phospho-Tyr 
(Tyr-p) SHP2, and Rock-1, as described in the legend to Fig. 3. β-actin 
was used as the internal control. The values shown are the quantitative 
density analysis expressed as the relative density compared to that in 
untreated cells (control), taken as 100%. The results are expressed as 
the mean ± S.D. for three separate experiments. *: p < 0.05 as com-
pared to the untreated control.
Figure 8 Arecoline inhibits hepatoma cell colony growth in soft 
agar. The growth of HA22T/VGH cells in soft agar was measured in 35 
mm diameter dishes with a lower layer of 0.7% agar solution and an 
upper layer of 0.35% agar solution in which 1 × 105 cells were resus-
pended. The soft agar was covered with culture medium alone or con-
taining the indicated concentration of arecoline. After 3 weeks, 
colonies larger than 0.1 mm in diameter were scored. (A) Representa-
tive photomicrographs of soft agar colonies at 200× magnification. 
The black arrows indicate colonies. (B) Number of colonies in the pres-
ence or absence of arecoline. The results are the mean ± S.D. for three 
independent experiments. *: p < 0.05; #: p < 0.001 as compared to the 
untreated control.Cheng et al. Molecular Cancer 2010, 9:126
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vate a mitochondrial death pathway and induce cardio-
myocyte apoptosis [30]. Rock is cleaved by caspase
during apoptosis to generate a truncated active form [19]
and several studies have indicated that Rock activation by
caspase-3 seems to be responsible for bleb formation in
apoptotic cells [19,31]. Our results clearly showed that
Rock-1 cleavage and Bax levels, mitochondrial cyto-
chrome c release, and apoptosis were increased by areco-
line treatment and that a RhoA inhibitor attenuated these
effects, showing that RhoA/Rock were involved.
Rho family GTPases and STAT3 regulate cell prolifera-
tion and gene induction, and their activating mutants are
known to be oncogenic [32,33]. Recently, several studies
have searched for their functional connection and
reported that Rho GTPase can activate STAT3 by induc-
tion of Tyr705 phosphorylation, and that activated
STAT3 can, in turn, mediate certain aspects of Rho
GTPase signaling [34-37]. Debidda et al. [37] reported
that genetic deletion of STAT3 leads to a loss of response
to RhoA in myosin light chain phosphorylation and actin
stress fiber induction, but sensitizes cells to RhoA- or
Rock-stimulated cell migration. In this study , we found
that inhibition of RhoA activation enhanced STAT3 acti-
vation in arecoline-treated HA22T/VGH cells, resulting
in a reduction in anoikis. These findings suggest that a
connection exists between STAT3 and the RhoA/Rock
signaling pathway. It is important to clarify how signaling
networks are controlled by arecoline through these two
important classes of intracellular signal molecules, but
there are not enough data in the present study to reveal
this complicated link. Further experiments are needed to
explore what transcriptional events and target genes that
are integral parts of anoikis of the RhoA/Rock signaling
paradigm are turned on by activated STAT3.
The HA22T/VGH cells used in this study are a poorly
differentiated hepatoma cell line lacking p53 expression
[38]. It has been demonstrated that the tumor suppressor
p53 can restrict RhoA activation [39,40]. This may mean
that, in HA22T/VGH cells, RhoA can be activated easily.
In unpublished experiments, we found more activated
RhoA and Rock-1 in HA22T/VGH cells than in a wild-
type p53 HepG2 hepatoma cell line and showed that
HA22T/VGH cells are more sensitive to arecoline-
induced anoikis than HepG2 cells. Accordingly, we pro-
pose that the p53 deletion in HA22T/VGH cells might
contribute to the activation of RhoA/Rock.
Previous studies have shown that SHP2 plays an essen-
tial role in integrin signaling. Dominant-negative mutants
of SHP2 inhibit integrin-stimulated focal adhesion and
stress fiber turnover, cell spreading, and proliferation
[12]. SHP2 promotes Src family kinase activation, allow-
ing SHP2 to regulate RhoA activity [18], and may also
participate in STAT3-related signaling [41]. We propose
that the reduction in SHP2 activation/phosphorylation
caused by arecoline might affect RhoA/Rock and STAT3
signal transduction and interfere with integrin signaling
and subsequently disrupt the cell-matrix interaction.
Although the cytotoxicity, genotoxic, and mutagenicity
of betel nut ingredients, including arecoline, have been
extensively investigated [42-44], there is only limited evi-
dence for carcinogenicity of arecoline in experimental
animals [45]. In in vitro studies, Jeng et al. [46,47] found
that arecoline significantly inhibits cell proliferation and
DNA synthesis in human oral mucosal fibroblasts at con-
centrations higher than 50 μg/ml, but does not induce
DNA strand breaks, even at concentrations of 400 μg/ml.
Sundqvist et al. [48] found that arecoline does not cause
significant DNA single strand breaks even at a concentra-
tion of 5 mM in cultured human buccal epithelial cells.
Lee et al. [49] demonstrated that arecoline induces both
cell necrosis and apoptosis in human KB epithelial cells at
concentrations of 0.2-1.2 mM. Thus, it seems that areco-
line concentrations higher than 0.2 mM may be toxic for
normal cells and further investigations are required to
determine whether low-dose (less than 0.2 mM or 85 μg/
Figure 9 Schematic representation of the arecoline-stimulated 
signaling pathways for detachment and apoptosis of HA22T/VGH 
cells. Arecoline treatment decreases IL-6 levels, but does not change 
gp130 of IL-6 receptor. In addition, phosphorylation/activation of 
STAT3, which provides protection against anoikis, is inhibited and lev-
els of its downstream signals IL-6, Bcl-2, and Bcl-XL are decreased, while 
Bax levels, mitochondrial cytochrome c release, caspase-9 levels, and 
caspase-3 activity are increased. Phosphorylation/activation of 
p190RhoGAP, a RhoA inhibitor, and its upstream regulator, SHP2, are 
inhibited, while the activation/cleavage of Rock-1, a RhoA downstream 
kinase, and actin stress fiber formation are increased, contributing to 
anoikis.Cheng et al. Molecular Cancer 2010, 9:126
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ml) arecoline is toxic. However, this study highlights the
possibility that low-dose arecoline might be useful in the
treatment of hepatoma and provides clues for studying
the arecoline-induced detachment of hepatoma cells.
Conclusions
We propose that arecoline induces anoikis of HA22T/
VGH cells that involves inhibition of STAT3 and
increased RhoA/Rock activation and that the STAT3 and
RhoA/Rock signaling pathways are connected. Impor-
tantly, this study shows that arecoline induces the death
of HA22T/VGH hepatoma cells, but not normal hepato-
cytes. Since arecoline has diverse biological functions,
additional studies are needed to evaluate its cytotoxicity
for other cells.
Methods
Reagents and antibodies
Arecoline hydrobromide (methyl 1-methyl-1,2,5,6-tetra-
hydronicotinate hydrobromide) was obtained from
Sigma-Aldrich (St. Louis, MO, USA); its purity was
greater than 99.0%. Collagenase type II was from Wor-
thington Biochemical Corporation (Lakewood, NJ, USA).
Percoll was from Amersham Pharmacia Biotech (Upp-
sala, Sweden). RNase A and the protease inhibitor cock-
tail were from Sigma-Aldrich (St. Louis, MO, USA).
Protein assay reagents were from Bio-Rad Laboratories
(Hercules, CA, USA). TRIzol reagent was from Invitro-
gen Life Technologies (Carlsbad, CA, USA). All other
chemicals were of analytical grade and purchased from
Sigma-Aldrich (St. Louis, MO, USA). The cell-permeable
RhoA inhibitor, C3 exoenzyme, was from Cytoskeleton
Inc. (Denver, CO, USA). Recombinant human IL-6 was
from Peprotech (Rocky Hill, NJ, USA). Mouse monoclo-
nal antibodies against phospho-tyrosine (phospho-Tyr),
phospho-Tyr705-STAT3, SHP2, p190RhoGAP, RhoA,
Rock-1, Bcl-2, Bax, procaspase-9, or cytochrome c, rabbit
polyclonal antibodies against Bcl-XL or gp130, and goat
polyclonal antibodies against β-actin were purchased
from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Horseradish peroxidase-conjugated anti-mouse, goat,
and rabbit IgG antibodies were purchased from BD
Pharmingen Inc. (San Diego, CA, USA). R-phycoerythrin
(RPE)-conjugated rabbit anti-active caspase-3 polyclonal
antibodies, RPE-conjugated mouse anti-human β1-integ-
rin monoclonal antibody and the RPE-conjugated mouse
IgG isotype control were purchased from BD Pharmin-
gen Inc. (San Diego, CA, USA). The RPE-conjugated rab-
bit IgG isotype control was from R&D Systems
(Minneapolis, MN, USA). FITC-conjugated swine anti-
goat IgG antibodies were from Invitrogen Corporation
(Camarillo, CA, USA).
Cell line, cell culture, and arecoline treatment
HA22T/VGH, a poorly differentiated human hepatoma
cell line, was obtained from the Bioresource Collection
and Research Center (BCRC) in the Food Industry
Research and Development Institute (Hsinchu, Taiwan)
and was cultured in Dulbecco's Modified Eagle's Medium
(DMEM) (Gibco BRL, Grand Island, NY, USA) contain-
ing 10% fetal bovine serum (FBS) (Hyclone, Auckland,
NZ), 2 mM L-glutamine (Gibco BRL, Grand Island, NY,
USA), 0.1 mM non-essential amino acids (Gibco BRL,
Grand Island, NY, USA), 100 units/ml of penicillin, and
100 μg/ml of streptomycin (Gibco BRL, Grand Island,
NY, USA) at 37°C in a humidified chamber with 5% CO2.
To investigate the effects of arecoline, various concentra-
tions of arecoline were added to the culture medium for
the indicated time period, then the cells were harvested
and analyzed.
Primary hepatocyte isolation
Hepatocytes were isolated using a previously described
method [50]. Sprague-Dawley rats were purchased from
BioLASCO T aiwan Co., Ltd. (Charles River T echnology,
Taipei, Taiwan). This study was performed in accordance
with the Guide for the Care and Use of Laboratory Ani-
mals of the United States National Institutes of Health.
The protocol for animal use was reviewed and approved
by the Institutional Animal Care and Use Committee
(IACUC) of Kaohsiung Medical University (Approval No.
96137). Livers from newborn Sprague-Dawley rats were
mechanically dissociated using a scalpel and the liver
pieces incubated in Hank's balanced salt solution (pH 7.4)
(HBSS) containing 0.6 mM EGTA and 2% bovine serum
albumin (BSA) (Ca2+-free) (Sigma-Aldrich, St. Louis,
MO, USA) by shaking for 10 min at 37°C followed by a
brief wash with HBSS. Hepatocytes were further dissoci-
ated from the tissue by shaking for 15 min at 37°C in
HBSS (pH 7.4) containing 5 mM CaCl2 and 1.5 mg/ml of
collagenase type II, then were filtered through a 70 μm
nylon cell strainer (BD Falcon, Bedford, MA, USA) to
remove cellular aggregates and tissue debris. The cell fil-
trate was centrifuged at 50 ×g for 10 min and the cell pel-
let resuspended in DMEM and centrifuged at 800 ×g for
30 min on a discontinuous Percoll gradient comprised of
3 ml of 70% and 6 ml of 30% Percoll. The dissociated cells
were stratified and viable hepatocytes were found at the
interface between the two Percoll layers. The hepatocyte
fraction was collected and the cells plated in flasks in
DMEM containing 10% FBS and allowed to attach for 2-3
h at 37°C in a humidified chamber with 5% CO2, then
were washed with DMEM to remove non-adherent
hematopoietic cells. The cells were fed with fresh
medium every other day and were split at 80-90% conflu-Cheng et al. Molecular Cancer 2010, 9:126
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ence. Experiments were performed on day 7-10 post-iso-
lation.
Cell morphology
Morphological changes were observed under an inverted
phase-contrast microscope (Olympus, Tokyo, Japan).
Photographs were taken at 200× magnification.
Cell viability assay
After arecoline treatment, the cells were harvested and
viable cells counted using a dye exclusion technique. The
cell suspension was centrifuged at 5 000 ×g, the superna-
tant discarded and the cell pellet resuspended in serum-
free medium. One volume of 0.4% Trypan blue (Gibco
BRL, Grand Island, NY, USA) was added to one volume of
cell suspension, then, after incubation at room tempera-
ture for 3 min, cells were counted in a hemocytometer.
All counts were done in triplicate.
Detection of cell surface adhesion molecules
HA22T/VGH cells were harvested and washed with
serum-free DMEM, then were suspended in DMEM con-
taining 1% BSA and incubated in the dark at 4°C for 30
min with RPE-conjugated mouse anti-human monoclo-
nal antibody against β1-integrin. After two washed with
1% BSA/phosphate-buffered saline (PBS), the cells were
fixed by mixing the cells with 4% paraformaldehyde in
PBS, then resuspended in 1% BSA/PBS for flow cytome-
try analysis. Cell fluorescence was measured using a
Coulter Epics XL cytometer (Beckman Coulter, Miami,
FL, USA). A control sample incubated with RPE-conju-
gated normal mouse IgG was run in parallel as a negative
control. The data were analyzed using WINMDI software
version 2.8 (Scripps Research Institute, La Jolla, CA,
USA), a minimum of 1 × 104 cells per sample being evalu-
ated in each case.
Apoptosis assay
Detection of active caspase-3
Active caspase-3 was detected as described previously
[51]. Briefly, cells were pelleted, resuspended in 1 ml of
4% paraformaldehyde, and incubated for 30 min at room
temperature. The suspension was then centrifuged, the
pellet washed twice with PBS, the cells resuspended in 1
ml of 0.1% Triton X-100 and incubated for 30 min at
room temperature, then washed as above. Labeling was
performed by addition of 100 μl of PBS containing 5 μl of
polyclonal RPE-conjugated rabbit anti-active caspase-3
antibodies, incubation at 37°C for 1 h, washing with PBS,
and analysis on a Coulter Epics XL cytometer (Beckman
Coulter, Miami, FL, USA). A control sample incubated
with RPE-conjugated normal rabbit IgG was run in paral-
lel. The data were analyzed using WINMDI software ver-
sion 2.8 (Scripps Research Institute, La Jolla, CA, USA), a
minimum of 1 × 104 cells per sample being evaluated in
each case.
DNA fragmentation assay
Cells (5 × 106) were treated with arecoline for 72 h, then
the adherent or detached cells were harvested separately
or pooled together for DNA fragmentation analysis as
described previously [52]. The cells were pelleted and
resuspended in 200 μl of lysis solution [10 mM Tris (pH
8.0), 100 mM NaCl, 25 mM EDTA, 0.5% sodium dodecyl
sulfate (SDS), 0.5 mg/ml proteinase K] and incubated for
15 h at 50°C. Nucleic acids were extracted by addition of
an equal volume of phenol/chloroform/isoamyl alcohol,
centrifugation for 20 min at 10 000 ×g 4°C, and harvesting
the aqueous (top) layer. DNA were precipitated by addi-
tion of a 1/2 volume of 7.5 M ammonium acetate and 2
volumes of 100% ethanol, and recovered by centrifuga-
tion at 10 000 ×g 4°C for 5 min. After rinsing with 70%
ethanol, the DNA was resuspended in TE buffer (10 mM
Tris, 1 mM EDTA, pH 8.0) and residual RNA removed by
addition of 10 μg/ml of RNase A and incubation at 60°C
for 1 h. Samples were resolved on a 1.5% Tris-acetate-
EDTA-agarose gel, which was stained with ethidium bro-
mide, and the bands visualized and photographed under
short-wave UV.
TUNEL assay
Terminal deoxynucleotide transferase-mediated dUTP
nick-end labeling (TUNEL) assays were performed using
an APO-BrdU™ TUNEL Assay Kit (Molecular Probes,
Eugene, OR) according to the manufacturer's protocol.
Briefly, the cells were incubated for the indicated time
before being trypsinized, washed with PBS, and fixed in
2% paraformaldehyde (pH 7.4) for 15 min. The fixed cells
were washed twice in PBS and stored at -20°C in 70% eth-
anol for 12-18 h prior to performing the TUNEL assay.
After removing the 70% ethanol by centrifugation, the
cells were washed twice in wash buffer, then incubated at
37°C for 60 min with DNA-labeling solution containing
terminal deoxynucleotidyl transferase and BrdUTP. After
washing twice with rinse buffer, the cells were resus-
pended for 30 min in the dark at room temperature in
antibody solution containing Alexa Fluor®  488-labeled
anti-BrdU antibody. Flow cytometric analysis was then
performed using a Coulter Epics XL cytometer (Beckman
Coulter, Miami, FL, USA) to quantify apoptosis. The data
w e r e  a n a l y z e d  u s i n g  W I N M D I  s o f t w a r e  v e r s i o n  2 . 8
(Scripps Research Institute, La Jolla, CA, USA), a mini-
mum of 1 × 104 cells per sample being evaluated in each
case.
Protein lysate preparation and Western blotting
Sample preparation and Western blotting procedures
were performed as described previously [53]. Briefly, cells
were harvested and cytosolic extracts prepared using lysis
buffer [20 mM Tris-HCl (pH 7.2), 2 mM EGTA, 5 mMCheng et al. Molecular Cancer 2010, 9:126
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EDTA, 500 μM sodium orthovanadate, 10 mM sodium
fluoride, 1% Triton X-100, 0.1% SDS and protease inhibi-
tor cocktail]. Protein concentrations were determined
using protein assay reagents. Forty to sixty micrograms of
protein lysate was analyzed by SDS-polyacrylamide gel
electrophoresis. After transfer of the proteins from the
gel to a nitrocellulose membrane (Amersham Pharmacia
Biotech, Freiburg, Germany), the membranes were
blocked for 1 h at room temperature in PBS with 0.05%
Tween 20 (PBS-T) containing 5% nonfat dry milk, then
incubated with specific primary antibodies and horserad-
ish peroxidase-conjugated secondary antibodies. For
reblotting of other proteins on the same membrane, anti-
bodies were stripped using heated 0.1 M glycine solution
(pH 2.0) three times and the membrane washed twice
with PBS-T. The immunoreactive bands were visualized
using an enhanced chemiluminescence kit (Perkin-Elmer
Life Sciences, Boston, MA, USA).
Stress fiber formation assay
Immunofluorescence staining
For actin staining, HA22T/VGH cells were incubated for
the indicated time before being washed with PBS, fixed
for 10 min at room temperature in 2% paraformaldehyde
in PBS, and permeabilized for 10 min at room tempera-
ture with 0.5% Triton X-100 in PBS. Filamentous actin
was stained for 1 h at 37°C with polyclonal goat anti-actin
antibodies in PBS, then for 1 h at 37°C with FITC-conju-
gated swine anti-goat IgG antibodies. Images were
obtained at 200× magnification using a Zeiss Axiovert
200 fluorescence microscope.
Flow cytometry analysis
HA22T/VGH cells were incubated for the indicated time
before being trypsinized, washed with PBS, fixed for 10
min at room temperature in 2% paraformaldehyde in
PBS, and permeabilized for 15 min on ice with 90% meth-
anol. Filamentous actin was then stained as above, and,
after washing with PBS, samples were analyzed on a
Coulter Epics XL cytometer (Beckman Coulter, Miami,
FL, USA). The data were analyzed using WINMDI soft-
ware version 2.8 (Scripps Research Institute, La Jolla, CA,
USA), a minimum of 1 × 104 cells per sample being evalu-
ated in each case.
Quantitative real-time PCR analysis
Total RNA was isolated using TRIzol reagent according
to the manufacturer's instructions. RNA samples (2 μg)
were reverse transcribed using random hexamer primers
and M-MLV reverse transcriptase (Promega Corpora-
tion, Madison, WI, USA) and the cDNA used for real-
time PCR performed on a MiniOpticon™ Real-Time PCR
Detection System (Bio-Rad Laboratories, Hercules, CA,
USA) using iQ™ SYBR® Green Supermix (Bio-Rad Labora-
tories, Hercules, CA, USA) following the manufacturer's
protocol. The PCR amplification reaction mixture (25 μl)
contained 50 ng of cDNA, 12.5 μl of SYBR Green Super-
mix, and 0.2 μM of the IL-6- or GAPDH-specific primer
pair. The optimal primer concentrations were determined
in preliminary experiments. PCR primers were designed
using Beacon Designer software version 2.0 (Premier Bio-
soft International, Palo Alto, CA, USA) and their
sequences were as follows: IL-6 forward, 5'-TCC TGG
TGT TGC CTG CTG-3'; reverse, 5'-TCG TTC TGA
AGA GGT GAG TGG-3' and GAPDH forward, 5'-GAC
ATC AAG AAG GTG GTG AAG CAG-3'; reverse, 5'-
GCG TCA AAG GTG GAG GAG TGG-3'. In order to
confirm amplification specificity, the PCR products from
each primer pair were subjected to melting curve analy-
sis. The reaction conditions were incubation at 50°C for 2
min and initial denaturation at 95°C for 10 min, followed
by 40 cycles of denaturation at 95°C for 20 s and anneal-
ing at 60°C for 1 min. After real-time PCR, the tempera-
ture was increased from 60 to 95°C at a rate of 0.5°C per
second to construct a melting curve. A negative control
without cDNA was run in parallel with each assay.
Results were collected and analyzed using MJ Opticon
Monitor Analysis software version 3.1 (Bio-Rad Labora-
tories, Hercules, CA, USA). Each reaction mixture was
amplified in triplicate and the results calculated based on
the ΔΔCt method [54]. The cycle threshold (Ct) value for
the IL-6 gene was corrected using the mean Ct value for
the GAPDH gene. Relative gene expression was expressed
as the fold change (2-ΔΔCt) relative to expression in the
untreated control.
Anchorage-independent growth in soft agar
A soft agar assay was performed as described previously
[33]. Briefly, growth in soft agar was measured in 35 mm
diameter dishes containing a lower layer of 0.7% agar
(Bitek agar; Difco Laboratories, Detroit, MI, USA) solu-
tion in DMEM containing 10% FBS and 0.1 mM non-
essential amino acids overlaid with 0.35% agar solution,
also in growth medium, in which 1 × 105 cells were resus-
pended. The soft agar was covered with culture medium
alone or containing the indicated concentration of areco-
line. Colonies were scored 21 days after preparation (col-
onies larger than ~0.1 mm in diameter were scored as
positive). Cells were maintained in DMEM with 10% FBS
and 0.1 mM non-essential amino acids.
Statistical analysis
All data are presented as the mean ± standard deviation
(S.D.) for the number of experiments indicated. Other
differences between treated and control groups were ana-
lyzed using Student's t-test. Statistical analyses were per-
formed using SAS version 6.011 (SAS Institute Inc, Cary,
NC). A p value < 0.05 was considered statistically signifi-
cant.Cheng et al. Molecular Cancer 2010, 9:126
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